Predictors of Rheumatic Immune-Related Adverse Events and De Novo Inflammatory Arthritis After Immune Checkpoint Inhibitor Treatment for Cancer.
Arthritis Rheumatol
; 74(3): 527-540, 2022 03.
Article
in En
| MEDLINE
| ID: mdl-34397169
Full text:
1
Database:
MEDLINE
Main subject:
Arthritis, Rheumatoid
/
Immune Checkpoint Inhibitors
/
Neoplasms
Type of study:
Etiology_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Arthritis Rheumatol
Year:
2022
Type:
Article